Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Tofacitinib vermindert overlijden of respiratoir falen door COVID-19
sep 2021 | Virale infecties